ReviewMikrochimica acta2026
Fluorescent nanozyme-based biosensors: Classification, catalytic mechanisms, and emerging applications.
Review in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fluorescent nanozymes have increasingly drawn attention as a unique type of nanozyme-like materials, whose value lies not in a single characteristic but in the combination of catalytic performance and fluorescence within one material system. Traditional nanozyme sensing systems are based on colorimetric detection methods that, although simple in operation, suffer from poor sensitivity and are easily influenced by coloured or turbid samples. The fluorescence approach addresses most of these issues, enabling sensitive detection, real-time monitoring of the signal, and suitability for microscale measurements-all of which play an important role in transferring research laboratory experiments into diagnostic tests at the point of care. In addition to sensitivity, fluorescent nanozymes still preserve such practical characteristics as high stability, long-term shelf life, cost-effective production, and tunability of surface chemistry for modulation of catalytic and fluorescent properties. In this review, recent progress in the field of fluorescent nanozyme-based biosensors has been analysed with an emphasis placed equally on accomplishments and limitations in the area. The classification of fluorescent nanozymes is explored based on different criteria, such as compositional, dimensional, catalytic and fluorescent types, as one single classification approach would be inadequate for describing the existing diversity of fluorescent nanozyme-based sensing platforms. A key aspect that needs to be considered is the catalytic reactions utilised to generate or enhance fluorescence signals, namely, peroxidase-like, oxidase-like and Fenton/Fenton-like mechanisms, with inherent mechanistic benefits and practical challenges associated with their utilisation that are not always addressed properly in experimental work. Potential applications of fluorescent nanozymes have also been discussed, particularly about performance that is relevant for each application domain, rather than just analytical capabilities. Concurrently, various issues are discussed in depth, including substrate specificity, that is often inadequate in most systems, insufficient understanding of catalysis mechanisms in many materials, fluorescence quenching due to biological matrices, and a lack of standardised testing protocols for nanozyme assays. The challenges mentioned above not only pose technical problems but also act as major hurdles for the further development of nanozyme technology to achieve translational validity. This review concludes by discussing strategies for developing highly selective and sensitive fluorescent nanozymes suitable for practical biosensing applications.
Indexed as
Identifiers
42665701What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.